CytomX Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
South San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
CytomX Therapeutics, Inc. has filed 794 SEC EDGAR filings since 28 Sep 2010

SEC filing history

Showing 476-500 of 794 matching filings.

Per page
25
Current page
20
4

FORM 4

Filing date
29 Jan 2019
Reporting date
25 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
29 Jan 2019
Reporting date
25 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
29 Jan 2019
Reporting date
25 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
29 Jan 2019
Reporting date
25 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
29 Jan 2019
Reporting date
25 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
27 Dec 2018
Reporting date
20 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
27 Dec 2018
Reporting date
20 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37587

8-K

Filing date
20 Dec 2018
Reporting date
19 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
14 Dec 2018
Reporting date
12 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
06 Dec 2018
Reporting date
30 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
06 Dec 2018
Reporting date
30 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 333-206658

CT ORDER filing

Filing date
19 Nov 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-37587

CT ORDER filing

Filing date
19 Nov 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-228203

S-3

Filing date
06 Nov 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37587

8-K FOR Q3 2018 EARNING RELEASE

Filing date
06 Nov 2018
Reporting date
06 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-37587

CTMX-2018-09-30-10-Q

Filing date
06 Nov 2018
Reporting date
30 Sep 2018
Next action
Verify source filing
4

FORM 4

Filing date
05 Nov 2018
Reporting date
01 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Nov 2018
Reporting date
01 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37587

8-K

Filing date
22 Oct 2018
Reporting date
22 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
02 Oct 2018
Reporting date
01 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
06 Sep 2018
Reporting date
04 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
06 Sep 2018
Reporting date
04 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37587

8-K

Filing date
08 Aug 2018
Reporting date
08 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
02 Aug 2018
Reporting date
01 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .